On September 22, 2020, Former Commissioner of the U.S. Food and Drug Administration Margaret Hamburg led a panel discussion exploring opportunities to leverage global resources and pre-competitive collaboration to foster innovation and identify sustainable solutions to combat Alzheimer’s disease.
World Economic Forum Sustainable Development Impact Summit – Affiliated Session
Previous
Previous
Global Cohorts Initiative: Increasing Targets for Drug Development
Next
Next

